US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) — Denver, Colorado

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, EGFR Positive Non-small Cell Lung Cancer, Colorectal Carcinoma.

Sponsors: Sumitomo Pharma America, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC)?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) conducted?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has 1 clinical trials on record. Their work covers Advanced Solid Tumors, EGFR Positive Non-small Cell Lung Cancer, Colorectal Carcinoma.

Is US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) accredited by Crixeo Clinical Trials?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.